InvestorsHub Logo
Followers 1171
Posts 34538
Boards Moderated 0
Alias Born 03/26/2007

Re: Rubberneck2 post# 3584

Monday, 05/17/2021 11:40:30 AM

Monday, May 17, 2021 11:40:30 AM

Post# of 13742
ReRead this portion of the recent News...The FDA will designate IND status for Escozine®, essentially allowing the drug to be distributed in the US.

https://finance.yahoo.com/news/medolife-rx-submits-final-data-123000200.html

After such designation, the Company will pursue other clinical applications of Escozine®, including as a potential cancer therapeutic where the Company has already released positive clinical results.

Very Very Clear to Understand and Comprehend what it Truly means Regarding this much awaited and well Anticipated FDA IND Approval news @ hand.

1) Essentialy Allowing Escozine® to be Distributed in the US.
2) To pursue Clinical Applications of Escozine®,including as a potential
cancer therapeutic where the Company has already released positive
clinical results.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.